Guangzhou, China

Dorathy Zeng

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Colgate Palmolive Company. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dorathy Zeng

Introduction

Dorathy Zeng is a prominent inventor based in Guangzhou, China. She has made significant contributions to the field of oral health through her innovative inventions. Her work focuses on developing effective solutions for common dental issues.

Latest Patents

Dorathy Zeng holds a patent for a high salt toothpaste and methods for using the same. This invention involves compositions and methods for treating and preventing conditions of the oral cavity, such as gingivitis. The toothpaste composition includes at least 5% sodium chloride, combined with a toothpaste base that contains a zinc salt, non-silica calcium carbonate abrasive, and humectant. This formulation is designed to be applied to the oral surfaces, including the teeth and gums, of patients in need of such treatment.

Career Highlights

Dorathy Zeng is currently employed at Colgate-Palmolive Company, where she continues to innovate in the field of dental care. Her work has been instrumental in advancing oral health products that benefit consumers worldwide.

Collaborations

Throughout her career, Dorathy has collaborated with notable colleagues, including Yun Xu and Pingdong Li. These partnerships have fostered a creative environment that encourages the development of groundbreaking dental solutions.

Conclusion

Dorathy Zeng's contributions to oral health through her innovative patent demonstrate her commitment to improving dental care. Her work at Colgate-Palmolive Company and collaborations with fellow inventors highlight the importance of teamwork in driving innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…